Magnetic Resonance Imaging-based Biopsy Strategies in Prostate Cancer Screening: A Systematic Review [0.03%]
基于磁共振的前列腺癌筛查活检策略系统评价
Ivo G Schoots,Hashim U Ahmed,Peter Albers et al.
Ivo G Schoots et al.
Background and objective: Prostate cancer (PCa) screening using prostate-specific antigen (PSA) thresholding and systematic biopsies reduces advanced disease presentations and cancer-specific mortality, but also leads to ...
Re: Rajal B. Shah, Gladell P. Paner, Liang Cheng, et al. Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer: Call for a Multidisciplinary Approach. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.02.029 [0.03%]
关于定义惰性前列腺癌的白皮书：多学科方法的呼吁欧洲泌尿外科杂志即将出版https://doi.org/10.1016/j.eururo.2025.02.029（Rajal B Shah, Gladell P Paner, Liang Cheng等）(genitourinary pathology society and international society of urological pathology)
Matthew R Cooperberg,Jeremy Grummet,Scott E Eggener
Matthew R Cooperberg
Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non-muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification Schemes [0.03%]
计算组织学人工智能(CHAI)增强高分级Ta非肌层浸润性膀胱癌多中心队列的风险分层：与当前欧洲泌尿外科协会和美国泌尿外科协会的分层方案进行比较
Sam S Chang,Bryn Launer,Vikram Narayan et al.
Sam S Chang et al.
Refining the Role of Androgen Deprivation Therapy After Radical Prostatectomy [0.03%]
根治性前列腺切除术后的雄激素剥夺治疗的定位再思考
Mutlay Sayan,Paul L Nguyen
Mutlay Sayan
Re: Bladder-preserving Trimodality Treatment for High-grade T1 Bladder Cancer: Results from Phase II Protocol NRG Oncology/RTOG 0926 [0.03%]
NRG肿瘤学/RTOG 0926Ⅱ期方案：高分级T1膀胱癌保膀胱三联治疗的疗效分析
Melinda Z Fu,Saum Ghodoussipour,Vignesh T Packiam
Melinda Z Fu
Re: Using Deep Learning To Differentiate Among Histology Renal Tumor Types in Computed Tomography Scans [0.03%]
基于CT扫描的肾脏肿瘤病理类型的深度学习鉴别诊断
Matteo Santoni,Francesco Massari
Matteo Santoni
Reply to Matthew R. Cooperberg, Jeremy Grummet, and Scott E. Eggener's Letter to the Editor re: Rajal B. Shah, Gladell P. Paner, Liang Cheng, et al. Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer: Call for a Multidisciplinary Approach. Eur Urol. In press. https: [0.03%]
关于Matthew R. Cooperberg，Jeremy Grummet和Scott E. Eggener致编辑部信件的回复：Rajal B. Shah，Gadell P. Paner，Liang Cheng等泌尿系统病理学会及国际泌尿病理学协会关于定义惰性前列腺癌的白皮书：呼吁采取多学科方法。Eur Urol. 在线发表。https:
Glen Kristiansen,Gladell P Paner,Rajal B Shah
Glen Kristiansen
Re: Veeru Kasivisvanathan, Vinson Wai-Shun Chan, Keiran D. Clement, et al. An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate Cancer. Eur Urol 2025;87:512-23 [0.03%]
关于Kasivisvanathan V, Chan VW, Clement KD等. 系统性经直肠超声检查与MRI目标活检检测前列腺癌的随机对照试验个体患者数据荟萃分析。 Eur Urol 2025;87:512-23
Sherryn Sherryn,Bagus Baskoro,Jie Sun
Sherryn Sherryn
Re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.03.018 [0.03%]
托马斯·德赖尔、西蒙妮·布兰特、努德·法布林等。Xpert Bladder Cancer Monitor 尿生物标志物检测在高分级非肌层浸润性膀胱癌 cystoscopy 指导中的应用：来自随机对照 DaBlaCa-15 试验的结果。Eur Urol. 在线发表中。https://doi.org/10.1016/j.eururo.2025.03.018
Xin Rui,Xiaoming Xu,Bo Dai
Xin Rui
Prevalence, Socioeconomic, and Environmental Costs of Urinary Incontinence in the European Union [0.03%]
欧盟尿失禁的流行率、社会经济和环境成本
Chrissy Bishop,Federico Rodriguez-Cairoli,Arnold Hagens et al.
Chrissy Bishop et al.
Background and objective: Up to 40% of the population suffers from urinary incontinence (UI). UI can be managed through qualified early assessment, possibly reducing associated health care costs. However, limited studies ...